Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

combretastatin A-4 disodium phosphate

Known as: CA4P, Combretastatin A4 Disodium Phosphate, Fosbretabulin Disodium 
The disodium salt of a water-soluble phosphate derivative of a natural stilbenoid phenol derived from the African bush willow (Combretum caffrum… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
Vascular-disrupting agents (VDAs) such as combretastatin A4 phosphate (CA4P) selectively disrupt blood vessels in tumors and… Expand
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
Review
2004
Review
2004
Tumor endothelium represents a valuable target for cancer therapy. The vasculature plays a critical role in the survival and… Expand
Is this relevant?
Review
2004
Review
2004
  • P. Thorpe
  • Clinical Cancer Research
  • 2004
  • Corpus ID: 1739027
Vascular targeting agents (VTAs) for the treatment of cancer are designed to cause a rapid and selective shutdown of the blood… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
2003
Highly Cited
2003
PURPOSE Combretastatin A4 phosphate (CA4P) is a novel vascular targeting agent. Dynamic contrast enhanced magnetic resonance… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
PURPOSE A phase I trial was performed with combretastatin A4 phosphate (CA4P), a novel tubulin-binding agent that has been shown… Expand
Is this relevant?
Highly Cited
2003
Highly Cited
2003
PURPOSE Combretastatin A4 (CA4) phosphate (CA4P) inhibits microtubule polymerization and is toxic to proliferating endothelial… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
Highly Cited
2002
Highly Cited
2002
Combretastatin A-4 phosphate (CA4P) is a novel antitumor vascular targeting agent, the first agent of this class of compounds to… Expand
  • figure 2
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
BACKGROUND AND PURPOSE The ability of combretastatin A-4 disodium phosphate (CA4DP) to induce vascular damage and enhance the… Expand
Is this relevant?
Highly Cited
1999
Highly Cited
1999
SummaryThe anti-tumour effects and mechanism of action of combretastatin A-4 and its prodrug, combretastatin A-4 disodium… Expand
  • figure 1
  • figure 2
  • table 2
  • table 1
  • table 3
Is this relevant?
Highly Cited
1998
Highly Cited
1998
PURPOSE The aim of this study was to evaluate the antitumor efficacy of combretastatin A-4 disodium phosphate (combretastatin… Expand
Is this relevant?